TENAX THERAPEUTICS, INC.（TENX）内部人交易：高管与董事近期交易
过去 18 个月，共有 8 位内部人为 TENAX THERAPEUTICS, INC.（TENX）报告了 36 笔 Form 4 交易（最近一笔 2026-09-17）。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-09-17 | Doogan Declan | 董事 | 买入 | 53,000 | $101,760 |
| 2026-09-15 | STAAB THOMAS R II | Chief Financial Officer | 买入 | 5,675 | $10,981 |
| 2026-09-15 | Giordano Christopher Thomas | CEO | 买入 | 6,000 | $11,250 |
| 2026-09-15 | Giordano Christopher Thomas | CEO | 买入 | 4,850 | $8,837 |
| 2026-09-08 | Schneeberger Daniel | 10% 以上股东 | 买入 | 900,000 | $1.6M |
| 2026-09-08 | ADAR1 Capital Management, LLC | 10% 以上股东 | 买入 | 900,000 | $1.6M |
| 2026-09-02 | Schneeberger Daniel | 10% 以上股东 | 买入 | 403,571 | $722,594 |
| 2026-09-02 | ADAR1 Capital Management, LLC | 10% 以上股东 | 买入 | 403,571 | $722,594 |
| 2026-09-02 | Schneeberger Daniel | 10% 以上股东 | 买入 | 179,058 | $321,570 |
| 2026-09-02 | ADAR1 Capital Management, LLC | 10% 以上股东 | 买入 | 179,058 | $321,570 |
| 2026-09-02 | Schneeberger Daniel | 10% 以上股东 | 买入 | 187,704 | $337,586 |
| 2026-09-02 | ADAR1 Capital Management, LLC | 10% 以上股东 | 买入 | 187,704 | $337,586 |
| 2026-08-24 | Schneeberger Daniel | 10% 以上股东 | 买入 | 202,124 | $359,538 |
| 2026-08-24 | ADAR1 Capital Management, LLC | 10% 以上股东 | 买入 | 202,124 | $359,538 |
| 2026-08-24 | Schneeberger Daniel | 10% 以上股东 | 买入 | 716,369 | $1.3M |
| 2026-08-24 | ADAR1 Capital Management, LLC | 10% 以上股东 | 买入 | 716,369 | $1.3M |
| 2026-08-24 | Schneeberger Daniel | 10% 以上股东 | 买入 | 107,374 | $188,355 |
| 2026-08-24 | ADAR1 Capital Management, LLC | 10% 以上股东 | 买入 | 107,374 | $188,355 |
| 2026-07-14 | Giordano Christopher Thomas | CEO | 买入 | 219 | $777 |
| 2026-07-14 | Giordano Christopher Thomas | CEO | 买入 | 8,500 | $50,490 |
| 2026-05-13 | STAAB THOMAS R II | Chief Financial Officer | 买入 | 10,000 | $0 |
| 2025-12-10 | Rich Stuart | Chief Medical Officer | 买入 | 2,500 | $25,250 |
| 2025-12-10 | Rich Stuart | Chief Medical Officer | 买入 | 2,500 | $25,550 |
| 2025-12-05 | Rich Stuart | Chief Medical Officer | 买入 | 1,000 | $9,010 |
| 2025-12-05 | Rich Stuart | Chief Medical Officer | 买入 | 1,500 | $13,620 |
来源：SEC Form 4 申报文件 · 截至 2026-09-17